Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin
This is a discussion on Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin within the Medical Articles and Abstracts forum; Journal: 1: Br J Haematol. 2003 Oct;123(1):103-5. Full Text Article: http://tinyurl.com/4djbx Tandem high-dose therapy (HDT) ...
noblood Home 
Resources
Medical Articles and Abstracts
Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin
| Notices |
Welcome to the latest in bloodless medicine and blood transfusion alternatives.
We are a community of medical professionals and members of the public who are responding to the worldwide concern about the efficacy, cost and availability of donor blood. |
|
|
LinkBack | Thread Tools | Search this Thread | Rate Thread | Display Modes |
 |
04-05-2005, 10:16 PM
|
||||
|
||||
|
Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin
Journal:
1: Br J Haematol. 2003 Oct;123(1):103-5. Full Text Article: http://tinyurl.com/4djbx Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion. Baron F, Frere P, Fillet G, Beguin Y. Department of Medicine, Division of Haematology, University of Liege, Liege, Belgium. We evaluated the ability of recombinant human erythropoietin (rHuEpo) therapy, given before high-dose therapy (HDT), to allow autologous peripheral blood stem cell transplantation (PBSCT) without red blood cell (RBC) transfusions. Eleven multiple myeloma patients underwent tandem HDT and autologous PBSC, receiving 500 U/kg/week rHuEpo from d 30 after initial transplant. Haemoglobin levels were 9.5 +/- 1.1 g/dl and 12.5 +/- 0.9 g/dl at the first and second transplant respectively (P < 0.001). RBC transfusions were required for 10/11 patients for the first transplant versus 1/11 for the second (P < 0.001). To conclude, a short course of rHuEpo therapy before HDT facilitates the performance of an autologous transplant without RBC transfusions. PMID: 14510949 [PubMed - indexed for MEDLINE] http://tinyurl.com/5py79     
|
|
| Tags |
| erythropoietin, erythropoietin (epo), hdt, myeloma, recombinant, stem cell therapy |
«
Previous Thread
|
Next Thread
»
| Currently Active Users Viewing This Thread: 1 (0 members and 1 guests) | |
| Thread Tools | Search this Thread |
| Display Modes | Rate This Thread |
Linear Mode
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Pediatric Use of Recombinant Human Erythropoietin | elizabeth | Ask a Professional | 4 | 06-07-2006 11:29 AM |
| Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah's Witness patients wit | Nika | Medical Articles and Abstracts | 0 | 04-06-2005 10:04 PM |
| Recombinant human erythropoietin therapy in low-birthweight preterm infants | Jan B. Wade | Medical Articles and Abstracts | 0 | 04-04-2005 10:09 AM |
| rHuEpo before high-dose therapy allows autologous peripheral stem-cell transp | Nika | Medical Articles and Abstracts | 0 | 03-18-2005 01:05 AM |
| The Role of Recombinant Human Erythropoietin in the Treatment of Thalassemia | Nika | Medical Articles and Abstracts | 0 | 03-16-2005 10:34 PM |
